arrow
返回
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Nature Reviews Drug Discovery 封面图
Nature Reviews Drug Discovery
IF:
101.8
论文数:
5.1K
被引数:
5.3W

机构

D
Dermatologikum Hamburg
学者数:
183
论文数: 179
被引数: 316
引用论文

引用论文

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris
err2004-01-05
err851
errOAAI
errLee, E; Trepicchio, WL; Oestreicher, JL; Pittman, D; Wang, F; Chamian, F; Dhodapkar, M; Krueger, JG
err分享
err收藏
err分享
err收藏
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis
err2006-10-01
err189
PREAI
errToichi, Eiko; Torres, Gisela; McCormick, Thomas S.; Chang, Timothy; Mascelli, Mary Ann; Kauffman, Catharine L.; Aria, Nancy; Gottlieb, Alice B.; Everitt, Daniel E.; Frederick, Bart; Pendley, Charles E.; Cooper, Kevin D.
err分享
err收藏
Medical progress - Psoriasis
err2005-05-05
err1.0K
PREAI
errSchon, MP; Boehncke, WH
err分享
err收藏
err分享
err收藏
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
errLANCET
IF88.5
err2009-02-01
err493
PREAI
errGottlieb, Alice; Menter, Alan; Mendelsohn, Alan; Shen, Yaung-Kaung; Li, Shu; Guzzo, Cynthia; Fretzin, Scott; Kunynetz, Rod; Kavanaugh, Arthur
err分享
err收藏
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
errLANCET
IF88.5
err2008-05-01
err1.4K
PREAI
errLeonardi, Craig L.; Kimball, Alexa B.; Papp, Kim A.; Yeilding, Newman; Guzzo, Cynthia; Wang, Yuhua; Li, Shu; Dooley, Lisa T.; Gordon, Kenneth B.
err分享
err收藏
学者 查看更多内容